R&D | April 17, 2026
Revvity aims to accelerate breakthroughs in cancer research
Revvity is positioning its technologies as a connected engine for discovery
Revvity is positioning its technologies as a connected engine for discovery
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
